Integer shareholders approve $5.7 billion acquisition by KKR
Integer Holdings’ stockholders voted to approve KKR’s proposed purchase of the company. The vote recorded 26,065,335 shares in favor, 10,513 against and 1,993 abstentions. The transaction, announced in August, is valued at $5.7 billion and is slated to close by the end of 2026 pending regulatory clearance. Debt financing for the deal is being arranged by Citigroup.
Why it matters
The approval clears a key hurdle for the $5.7 billion deal, allowing KKR to move toward closing and provide Integer with long‑term capital and greater flexibility as a portfolio company. The transaction also signals a sizable M&A activity in the medical‑device CDMO sector.
Key facts
- 1Shareholders approved the acquisition with 26,065,335 votes for, 10,513 against and 1,993 abstaining. medicaldesignandoutsourcing.com
- 2The deal is valued at $5.7 billion. medicaldesignandoutsourcing.com
- 3Closing is expected by the end of 2026, subject to regulatory approvals. medicaldesignandoutsourcing.com
- 4Citigroup is leading preparations for debt financing to support the transaction. marketscreener.com
- 5Integer’s stock has risen 61.55% year‑to‑date. marketscreener.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.